Fast But Durable Megakaryocyte Repopulation and Platelet Production in NOD/SCID Mice Transplanted with Ex‐Vivo Expanded Human Cord Blood CD34 + Cells
Open Access
- 1 March 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 22 (2) , 135-143
- https://doi.org/10.1634/stemcells.22-2-135
Abstract
We have previously established a stroma‐free culture with Flt‐3 ligand (FL), stem cell factor (SCF), and thrombopoietin (TPO) that allows the maintenance and the expansion for several weeks of a cord blood (CB) CD34+ cell population capable of multilineage and long‐lasting hematopoietic repopulation in non‐obese diabetic/ severe combined immunodeficient (NOD/SCID) mice. In this work the kinetics of megakarocyte (Mk)‐engraftment that is often poor and delayed in CB transplantation, and human platelet (HuPlt) generation in NOD/SCID mice of baseline CD34+ cells (b34+), and of CD34+ cells reisolated after a 4‐week expansion with FL+SCF+TPO (4w34+) were compared. With b34+ cells Mk‐engraftment was first seen at week 3 (CD41+: 0.4%); 4w34+ cells allowed a more rapid Mk‐engraftment (at weeks 2 and 3 the CD41+ cells were 0.3% and 0.8%). Circulating HuPlts were first seen at weeks 2 and 1, respectively. Mk‐engraftment levels of b34+ and 4w34+ cells 6–8 weeks after transplantation were similar (12 ± 3.5 versus 15 ± 5% CD45+; 1.3 ± 0.5 versus 1.8 ± 0.5% CD41+ cells). Also serial transplant experiments were performed with expanded and reselected CB cells. In secondary and tertiary recipients the Mk population was detected with bone marrow fluorescence‐activated cell sorter analysis; these experiments indicate the effective long‐term repopulation of expanded cells. Selected CD34+ cells after a 4‐week expansion with FL+SCF+TPO are more efficient in Mk engraftment than the same number of unmanipulated cells.Keywords
This publication has 26 references indexed in Scilit:
- Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID miceBlood, 2002
- Hematopoietic Stem-Cell Transplants Using Umbilical-Cord BloodNew England Journal of Medicine, 2001
- Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated DonorsNew England Journal of Medicine, 2001
- Umbilical cord blood transplantsCurrent Opinion in Hematology, 2000
- Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptorJournal of Clinical Investigation, 2000
- Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology systemCytometry, 1999
- Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated DonorsNew England Journal of Medicine, 1998
- Outcome of Cord-Blood Transplantation from Related and Unrelated DonorsNew England Journal of Medicine, 1997
- Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapyNature Medicine, 1996
- Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated RecipientsNew England Journal of Medicine, 1996